By Tom Fish ( July 20, 2026, 1:22 PM BST) -- Samsung Biologics said Monday it has agreed to acquire Swiss drug manufacturer PolyPeptide Group in an all-cash deal worth 1.46 billion Swiss francs ($1.8 billion), accelerating the South Korean company's expansion into the growing peptide biopharmaceutical sector....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.